← Back to headlines
Supernus Completes $350M Acquisition of Navitor Assets
Supernus Pharmaceuticals has finalized the acquisition of Navitor Pharmaceuticals' SPN-820 assets in a deal valued at $350 million. This strategic move expands Supernus's portfolio.
8 Apr, 05:20 — 8 Apr, 05:20
Sources
Showing 1 of 1 sources
